Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 303

1.
2.

Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females.

Yih WK, Greene SK, Zichittella L, Kulldorff M, Baker MA, de Jong JL, Gil-Prieto R, Griffin MR, Jin R, Lin ND, McMahill-Walraven CN, Reidy M, Selvam N, Selvan MS, Nguyen MD.

Vaccine. 2016 Jan 2;34(1):172-8. doi: 10.1016/j.vaccine.2015.09.087. Epub 2015 Nov 6.

3.

Overall conceptual framework for studying the genetics of autoimmune diseases following vaccination: a regulatory perspective.

Lababidi S, Sutherland A, Krasnicka B, Forshee RA, Anderson SA.

Biomark Med. 2015 Nov;9(11):1107-20. doi: 10.2217/bmm.15.67. Epub 2015 Nov 3.

PMID:
26526761
4.
5.

Reference set for performance testing of pediatric vaccine safety signal detection methods and systems.

Brauchli Pernus Y, Nan C, Verstraeten T, Pedenko M, Osokogu OU, Weibel D, Sturkenboom M, Bonhoeffer J; GRIP consortium.

Vaccine. 2015 Oct 20. pii: S0264-410X(15)01428-0. doi: 10.1016/j.vaccine.2015.10.013. [Epub ahead of print]

PMID:
26496461
6.

Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012.

Haber P, Moro PL, Cano M, Vellozzi C, Lewis P, Woo EJ, Broder K.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):205-13. doi: 10.1093/jpids/piu034. Epub 2014 May 7.

PMID:
26407428
7.

Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012.

Haber P, Moro PL, Cano M, Vellozzi C, Lewis P, Woo EJ, Broder K.

J Pediatric Infect Dis Soc. 2015 Mar;4(1):82-3. doi: 10.1093/jpids/piu123. Epub 2014 Dec 18. No abstract available.

PMID:
26407365
8.

Can Natural Language Processing Improve the Efficiency of Vaccine Adverse Event Report Review?

Baer B, Nguyen M, Woo EJ, Winiecki S, Scott J, Martin D, Botsis T, Ball R.

Methods Inf Med. 2015 Sep 23;54(5). [Epub ahead of print]

PMID:
26394725
9.

Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.

Felicetti P, Trotta F, Bonetto C, Santuccio C, Brauchli Pernus Y, Burgner D, Chandler R, Girolomoni G, Hadden RD, Kochar S, Kucuku M, Monaco G, Ozen S, Pahud B, Phuong L, Bachtiar NS, Teeba A, Top K, Varricchio F, Wise RP, Zanoni G, Živkovic S, Bonhoeffer J; Brighton Collaboration Vasculitis Working Group.

Vaccine. 2015 Sep 21. pii: S0264-410X(15)01293-1. doi: 10.1016/j.vaccine.2015.09.027. [Epub ahead of print]

PMID:
26392009
10.

Identification of sex-associated network patterns in Vaccine-Adverse Event Association Network in VAERS.

Zhang Y, Wu P, Luo Y, Tao C.

J Biomed Semantics. 2015 Aug 19;6:33. doi: 10.1186/s13326-015-0032-2. eCollection 2015.

11.

Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.

Iqbal S, Shi J, Seib K, Lewis P, Moro PL, Woo EJ, Shimabukuro T, Orenstein WA.

Lancet Infect Dis. 2015 Oct;15(10):1175-82. doi: 10.1016/S1473-3099(15)00059-6. Epub 2015 Aug 16.

PMID:
26289956
12.

Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.

Haber P, Parashar UD, Haber M, DeStefano F.

Vaccine. 2015 Sep 11;33(38):4873-7. doi: 10.1016/j.vaccine.2015.07.054. Epub 2015 Aug 11.

PMID:
26276687
13.

The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases.

Baker B, Eça Guimarães L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y.

Expert Opin Drug Saf. 2015;14(9):1387-94. doi: 10.1517/14740338.2015.1073710. Epub 2015 Jul 28.

PMID:
26216756
14.

Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: Clinical features and risk factors.

De Serres G, Rouleau I, Skowronski DM, Ouakki M, Lacroix K, Bédard F, Toth E, Landry M, Dupré N.

Vaccine. 2015 Aug 26;33(36):4464-71. doi: 10.1016/j.vaccine.2015.07.028. Epub 2015 Jul 22.

15.

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

Shimabukuro TT, Nguyen M, Martin D, DeStefano F.

Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22. Review.

16.
17.

A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden.

Feltelius N, Persson I, Ahlqvist-Rastad J, Andersson M, Arnheim-Dahlström L, Bergman P, Granath F, Adori C, Hökfelt T, Kühlmann-Berenzon S, Liljeström P, Maeurer M, Olsson T, Örtqvist Å, Partinen M, Salmonson T, Zethelius B.

J Intern Med. 2015 Oct;278(4):335-53. doi: 10.1111/joim.12391. Epub 2015 Jun 30. Review.

PMID:
26123389
18.

Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease.

Han J, Kemiki O, Hsu LL, Rivers AE.

Pharmacotherapy. 2015 Jul;35(7):696-700. doi: 10.1002/phar.1607. Epub 2015 Jun 19.

PMID:
26095207
19.

Advanced Clinical Decision Support for Vaccine Adverse Event Detection and Reporting.

Baker MA, Kaelber DC, Bar-Shain DS, Moro PL, Zambarano B, Mazza M, Garcia C, Henry A, Platt R, Klompas M.

Clin Infect Dis. 2015 Sep 15;61(6):864-70. doi: 10.1093/cid/civ430. Epub 2015 Jun 9.

PMID:
26060294
20.

Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).

Wei L, Scott J.

Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):922-33. doi: 10.1002/pds.3797. Epub 2015 Jun 4.

PMID:
26045284
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk